Mind Medicine (MNMD) Misses Q2 EPS by 23c

Mind Medicine (NASDAQ: MNMD) reported Q2 EPS of ($0.76), $0.23 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings